June 10th

Cardica to Host Investor Briefing on \'Revolutionizing Revascularization\'

Cardica, Inc. (Nasdaq: CRDC) today announced that it will webcast an investor briefing on the topic of \"Revolutionizing Revascularization\" on Thursday, June 12, at 5:15 p.m. Eastern Time in Boston. The event will feature a panel of renowned cardiovascular surgeons who will discuss how surgeons are integrating new techniques to improve coronary artery bypass graft (CABG) procedures, including the use of Cardica\'s C-Port(R) Distal Anastomosis Systems, which are designed to allow surgeons to automate the attachment of blood vessel grafts during CABG procedures, replacing traditional hand-sewn sutures. The Company also announced that data from the 220-patient prospective, randomized pivotal clinical trial of its PAS-Port(R) Proximal Anastomosis System will be presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) in Boston. The presentation, entitled \"The Cardica PAS-Port Proximal Anastomotic Connector Device: First Report of the Results of the FDA Trial,\" will be given during the Late Breaking News session on Thursday, June 12, at 1:15 p.m. Eastern Time by principal study investigator John D. Puskas, M.D., chief of cardiac surgery at Emory Crawford Long Hospital in Atlanta. As previously announced, the trial, which compared graft vessel connections made using the PAS-Port system to conventional hand-sewn sutures during CABG procedures, achieved all of its primary and secondary endpoints. Based on the positive trial data, Cardica submitted a 510(k) premarket notification in April to the U.S. Food and Drug Administration for the PAS-Port system.

Panelists for the investor event will include:

-- Husam H. Balkhy, M.D., chairman of cardiothoracic surgery at The Wisconsin Heart Hospital and clinical assistant professor of surgery at the Medical College of Wisconsin. He is a well-known advocate of minimally-invasive cardiac surgery and has the largest experience in the United States with distal anastomotic devices in coronary artery bypass.

-- Robert S. Poston, M.D., chief of cardiac surgery at Boston Medical Center. Previously, he was an associate professor of surgery at the University of Maryland where he focused his activities in the field of off-pump and minimally-invasive/robotic CABG. His research into minimally-invasive CABG and the hybrid procedure was recognized in 2005 by the Daily Record magazine as an \"Innovation of the Year.\"

-- Sudhir Srivastava, M.D., director of robotic and minimally-invasive cardiac surgery at the University of Chicago Medical Center. He pioneered both the da Vinci revascularization and port-only coronary artery bypass surgical methods and has performed more of these procedures than any other surgeon in the world.

Webcast Details

The event will be webcast live on Thursday, June 12, at 5:15 p.m. Eastern Time. To access the live and subsequently archived webcast of the discussion, go to the Investor Relations section of Cardica\'s website at http://www.cardica.com. Please connect to the website at least 15 minutes prior to the webcast to allow for any necessary software downloads.

About Cardica

Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica\'s products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica\'s C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has submitted a 510(k) premarket notification for clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures.

SOURCE Cardica, Inc.